Correlation Between Iovance Biotherapeutics and Axsome Therapeutics
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Axsome Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Axsome Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Axsome Therapeutics, you can compare the effects of market volatilities on Iovance Biotherapeutics and Axsome Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Axsome Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Axsome Therapeutics.
Diversification Opportunities for Iovance Biotherapeutics and Axsome Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Iovance and Axsome is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Axsome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axsome Therapeutics and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Axsome Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axsome Therapeutics has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Axsome Therapeutics go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Axsome Therapeutics
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the Axsome Therapeutics. In addition to that, Iovance Biotherapeutics is 1.95 times more volatile than Axsome Therapeutics. It trades about -0.09 of its total potential returns per unit of risk. Axsome Therapeutics is currently generating about 0.18 per unit of volatility. If you would invest 9,035 in Axsome Therapeutics on August 30, 2024 and sell it today you would earn a total of 930.00 from holding Axsome Therapeutics or generate 10.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iovance Biotherapeutics vs. Axsome Therapeutics
Performance |
| Timeline |
| Iovance Biotherapeutics |
| Axsome Therapeutics |
Iovance Biotherapeutics and Axsome Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iovance Biotherapeutics and Axsome Therapeutics
The main advantage of trading using opposite Iovance Biotherapeutics and Axsome Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Axsome Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will offset losses from the drop in Axsome Therapeutics' long position.| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
| Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |